Gilead Sciences Inc (XTER:GIS)
€ 125.9 -0.020 (-0.02%) Market Cap: 155.33 Bil Enterprise Value: 175.10 Bil PE Ratio: 0 PB Ratio: 15.28 GF Score: 80/100

Gilead Sciences, Inc. at Cantor Global Healthcare Conference Transcript

Sep 10, 2026 / 02:55 PM GMT


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GILD.OQ - Gilead Sciences, Inc.
Gilead Sciences, Inc. at Cantor Global Healthcare Conference
Sep 10, 2026 / 02:55PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Okay, great. And thank you for joining us in day two of the Canner Global Healthcare Conference. My name is Carter Gould. I cover the large cap biopharma names here at Canner. I'm pleased to welcome Gilead to the stage. Joining us is Andy Dickinson, CFO. Jackie Ross from IR and Treasury is also in the crowd someplace.

Andy, before we get started, maybe just any opening comments and then we'll jump into Q&A.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Sure. Well, first of all, thank you for having us. We appreciate it. It's great to be here.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot